PE72599A1 - Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros - Google Patents

Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros

Info

Publication number
PE72599A1
PE72599A1 PE1998000335A PE00033598A PE72599A1 PE 72599 A1 PE72599 A1 PE 72599A1 PE 1998000335 A PE1998000335 A PE 1998000335A PE 00033598 A PE00033598 A PE 00033598A PE 72599 A1 PE72599 A1 PE 72599A1
Authority
PE
Peru
Prior art keywords
cox
alkyl
carprophen
phenyl
dogs
Prior art date
Application number
PE1998000335A
Other languages
English (en)
Spanish (es)
Inventor
Lundy Kristin Marie Marie
Anthony Paul Ricketts
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PE72599A1 publication Critical patent/PE72599A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
PE1998000335A 1997-05-05 1998-05-04 Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros PE72599A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05

Publications (1)

Publication Number Publication Date
PE72599A1 true PE72599A1 (es) 1999-08-12

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000335A PE72599A1 (es) 1997-05-05 1998-05-04 Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros

Country Status (32)

Country Link
EP (1) EP0988034A1 (hr)
JP (1) JP2000513020A (hr)
KR (2) KR20010012300A (hr)
CN (1) CN1255059A (hr)
AP (1) AP9801234A0 (hr)
AR (2) AR011726A1 (hr)
AU (1) AU6932198A (hr)
BG (1) BG103852A (hr)
BR (1) BR9808720A (hr)
CA (1) CA2288759A1 (hr)
DZ (1) DZ2479A1 (hr)
EA (1) EA003696B1 (hr)
GT (1) GT199800063A (hr)
HR (1) HRP980244A2 (hr)
HU (1) HUP0001286A3 (hr)
ID (1) ID21311A (hr)
IL (1) IL132570A0 (hr)
IS (1) IS5220A (hr)
MA (1) MA26491A1 (hr)
NO (1) NO995389L (hr)
NZ (1) NZ500183A (hr)
OA (1) OA11213A (hr)
PA (1) PA8450601A1 (hr)
PE (1) PE72599A1 (hr)
PL (1) PL337003A1 (hr)
SK (1) SK148199A3 (hr)
TN (1) TNSN98059A1 (hr)
TW (1) TW590773B (hr)
UY (1) UY24989A1 (hr)
WO (1) WO1998050033A1 (hr)
YU (1) YU55899A (hr)
ZA (1) ZA983722B (hr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
EP1123091A1 (en) * 1998-10-23 2001-08-16 Merck Frosst Canada & Co. Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
EP1637137A3 (en) * 1999-03-10 2006-07-05 G.D. Searle LLC Method and composition for administering a cyclooxygenase-2 inhibitor to animals
AU1592901A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
AU2001259974A1 (en) * 2000-05-15 2001-11-26 Merck Frosst Canada & Co Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
EA200802070A1 (ru) 2000-06-13 2009-06-30 Вайет Болеутоляющее и противовоспалительные составы, содержащие ингибиторы циклооксигеназы-2
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
WO2002012549A1 (en) 2000-08-07 2002-02-14 Vanderbilt University Compositions and methods for detecting and quantifying cox-2 activity and 2-arachidonylglycerol metabolites
AU2002354901A1 (en) * 2001-07-16 2003-03-03 Edward Hogestatt Compounds with analgesic, antipyretic and/or anti-inflammatory activity
ATE342722T1 (de) 2003-05-07 2006-11-15 Osteologix As Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen
KR100780983B1 (ko) * 2003-07-31 2007-11-30 파마시아 앤드 업존 캄파니 엘엘씨 소염제의 분산성 제제
EP1940380A2 (en) * 2005-05-20 2008-07-09 Pfizer Limited Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-2 delta-ligands
US9114071B2 (en) 2007-04-04 2015-08-25 Sigmoid Pharma Limited Oral pharmaceutical composition
JP2010527285A (ja) 2007-04-26 2010-08-12 シグモイド・ファーマ・リミテッド 複数のミニカプセルの製造
ES2649112T3 (es) 2009-05-18 2018-01-10 Sigmoid Pharma Limited Composición que comprende gotas de aceite
WO2011018504A2 (en) 2009-08-12 2011-02-17 Sigmoid Pharma Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
WO2015134792A1 (en) 2014-03-06 2015-09-11 Aratana Therapeutics, Inc. Compositions of grapiprant and methods for using the same
BR112017009510A2 (pt) 2014-11-07 2017-12-19 Sigmoid Pharma Ltd composições compreendendo ciclosporina
CN107106536A (zh) * 2015-01-09 2017-08-29 美洲豹动物健康公司 治疗伴侣动物的腹泻的方法
US20230174485A1 (en) * 2020-03-25 2023-06-08 Sri International Lipoxygenase inhibitors
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions

Also Published As

Publication number Publication date
AR039628A2 (es) 2005-03-02
PL337003A1 (en) 2000-07-31
CN1255059A (zh) 2000-05-31
HRP980244A2 (en) 1999-02-28
DZ2479A1 (fr) 2003-02-01
NZ500183A (en) 2002-04-26
KR20010012300A (ko) 2001-02-15
MA26491A1 (fr) 2004-12-20
OA11213A (en) 2003-07-14
BG103852A (en) 2000-06-30
CA2288759A1 (en) 1998-11-12
NO995389L (no) 2000-01-04
GT199800063A (es) 1999-10-26
EA199900895A1 (ru) 2000-06-26
HUP0001286A2 (hu) 2000-11-28
BR9808720A (pt) 2000-07-11
ID21311A (id) 1999-05-20
SK148199A3 (en) 2001-09-11
IS5220A (is) 1999-10-19
WO1998050033A1 (en) 1998-11-12
YU55899A (sh) 2003-08-29
TNSN98059A1 (fr) 2005-03-15
AR011726A1 (es) 2000-08-30
KR20040004406A (ko) 2004-01-13
ZA983722B (en) 1999-11-04
EA003696B1 (ru) 2003-08-28
TW590773B (en) 2004-06-11
HUP0001286A3 (en) 2000-12-28
NO995389D0 (no) 1999-11-04
UY24989A1 (es) 2001-10-25
IL132570A0 (en) 2001-03-19
AU6932198A (en) 1998-11-27
PA8450601A1 (es) 2000-05-24
AP9801234A0 (en) 1999-11-04
JP2000513020A (ja) 2000-10-03
EP0988034A1 (en) 2000-03-29

Similar Documents

Publication Publication Date Title
PE72599A1 (es) Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros
ES2170252T3 (es) Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde.
NI200300042A (es) Compuestos que modulan la actividad de ppar y metodos para su preparacion.
AR036114A1 (es) Tetrahidroimidazol[1,2-a]pirazinas y tetrahidrotriazol[4,3-a]pirazinas como inhibidores de la dipeptidil peptidasa utiles para el tratamiento o la prevencion de la diabetes
AR027518A1 (es) Inhibidores de girasas y usos de los mismos
CR7865A (es) Derivados de dihidropiranoindol -3,4-diona sustituidos y derivados de 2-hidroximetilindol del acido 3-oxoacetico sustituidos como inhibidores del inhibidor del activador del plasminogeno 1(pai-1)
PE20040411A1 (es) Compuestos de aril cetona pirrolo triazina
NI200500087A (es) Derivados 4-tetrazolyl-4 fenilpiperidina para el tratamiento del dolor
ES2192588T3 (es) 4-(arilaminometilen)-2,4-dihidro-pirazol-3-onas.
PA8501801A1 (es) Inhibidores triciclicos de polimerasas (adp - polirribosas)
UY27370A1 (es) Derivados de benzamida tiazol y composiciones farmacéuticas para inhibir la proliferación de células y métodos para su utilización
ES2183937T3 (es) Inhibidores de la adhesion celular.
ES2177112T3 (es) Agentes angiostaticos y composiciones para tratar el glaucoma glc1a.
AR035417A1 (es) Derivados triciclicos de lactama y sultama, procesos para su elaboracion, medicamentos que los contienen, y el uso de dichos compuestos en la preparacion de medicamentos
ES2421948T3 (es) Compuestos y composiciones para suministrar agentes activos
AR054550A1 (es) Metodos para tratar la epileptogenesis
ES2164924T3 (es) Antibioticos de cefalosporina.
AR052885A1 (es) Metodos para el control del intervalo qt
UY28048A1 (es) Inhibidores de hiv-integrasa,composiciones farmacéuticas y métodos para su uso
ES543282A0 (es) Procedimiento para preparar nuevas bis-(4-aminofenil)-sulfo-nas substituidas
UY31866A (es) Combinaciones farmacéuticas comprendiendo los compuestos 3-z[1-(4-(n-((4-metil-piperazin-1-il)-metilcarbonil)-n-metil-amino)-anilino)-1-fenil-metilene]-6-metoxicarbonil-2-indolinona y el ácido n-[4-[2-(2-amino-4,7-dihidro-4-oxo-1h-pirrolo [2,3-d] pirimidin-5-il)etil]benzoil]-l-glutamico; sus sales farmacéuticamente aceptables y aplicaciones
UY26847A1 (es) Derivados de la pirrolidina
SE9702563D0 (sv) Compounds
PE35196A1 (es) Derivado de benzamidina util como antagonista de ltb4
PE20230679A1 (es) Inhibidores heterociclicos de pad4

Legal Events

Date Code Title Description
FC Refusal